読み込み中
TransMedics Group, Inc. operates as a commercial-stage medical technology enterprise, committed to transforming the landscape of organ transplant therapy for patients worldwide grappling with end-stage organ failure. At the core of their offerings is the Organ Care System (OCS), an innovative, portable solution engineered to perfuse, optimize, and continuously monitor donor organs. This system leverages exclusive, tailored technology to meticulously recreate near-physiological conditions for these vital organs while they remain outside the human body. The OCS suite encompasses specialized modules: OCS LUNG, which facilitates the preservation of standard criteria donor lungs for double-lung transplants; OCS Heart, designed for the extracorporeal perfusion and maintenance of donor hearts; and OCS Liver, dedicated to the preservation of donor livers. Founded in 1998, TransMedics is headquartered in Andover, Massachusetts.
前日終値
$77.87
−$1.13 · -1.43%
日中の時刻はETです。市場データは遅延する場合があります。
TransMedics Group, Inc. operates as a commercial-stage medical technology enterprise, committed to transforming the landscape of organ transplant therapy for patients worldwide grappling with end-stage organ failure. At the core of their offerings is the Organ Care System (OCS), an innovative, portable solution engineered to perfuse, optimize, and continuously monitor donor organs. This system leverages exclusive, tailored technology to meticulously recreate near-physiological conditions for these vital organs while they remain outside the human body. The OCS suite encompasses specialized modules: OCS LUNG, which facilitates the preservation of standard criteria donor lungs for double-lung transplants; OCS Heart, designed for the extracorporeal perfusion and maintenance of donor hearts; and OCS Liver, dedicated to the preservation of donor livers. Founded in 1998, TransMedics is headquartered in Andover, Massachusetts.
日中レンジ
現在 $77.87
52週レンジ
現在 $77.87
日中の時刻はETです。市場データは遅延する場合があります。
GoAI スコア
中立
バリュエーション
87
大幅な割安
センチメント
78
強気
リスク
71
高リスク
モメンタム
25
弱含み
GoAIの詳細リサーチ
詳しい根拠、カタリスト、リスクを確認できます。
TransMedics Group, Inc. operates as a commercial-stage medical technology enterprise, committed to transforming the landscape of organ transplant therapy for patients worldwide grappling with end-stage organ failure. At the core of their offerings is the Organ Care System (OCS), an innovative, portable solution engineered to perfuse, optimize, and continuously monitor donor organs. This system leverages exclusive, tailored technology to meticulously recreate near-physiological conditions for these vital organs while they remain outside the human body. The OCS suite encompasses specialized modules: OCS LUNG, which facilitates the preservation of standard criteria donor lungs for double-lung transplants; OCS Heart, designed for the extracorporeal perfusion and maintenance of donor hearts; and OCS Liver, dedicated to the preservation of donor livers. Founded in 1998, TransMedics is headquartered in Andover, Massachusetts.
日中レンジ
現在 $77.87
52週レンジ
現在 $77.87
利用可能な期間全体で報告されたマージン。
売上高
営業利益
純利益
| 指標（USD） | 2025年度 | 2024年度 | 2023年度 | 2022年度 | 2021年度 |
|---|---|---|---|---|---|
| 売上高 | 6.05億 USD | 4.42億 USD | 2.42億 USD | 9345.9万 USD | 3026.2万 USD |
| 売上原価 | 2.43億 USD | 1.79億 USD | 8753万 USD | 2818.7万 USD | 910.3万 USD |
| 粗利益 | 3.63億 USD | 2.62億 USD | 1.54億 USD | 6527.2万 USD | 2115.9万 USD |
| 研究開発 | 6905.5万 USD | 5596.8万 USD | 6326.7万 USD | 2681.2万 USD | 2230.4万 USD |
| 販売・一般管理 | 1.85億 USD | 1.69億 USD | 1.2億 USD | 6989.7万 USD | 3828.3万 USD |
| 営業費用 | 2.54億 USD | 2.25億 USD | 1.83億 USD | 9670.9万 USD | 6058.7万 USD |
| 受取利息 | — | — | 1250万 USD | 90万 USD | — |
| 支払利息 | 1378.2万 USD | 1440.9万 USD | 1079.1万 USD | 372.6万 USD | 387.4万 USD |
| 減価償却費と償却費 | 2718.5万 USD | 1975.8万 USD | 817.7万 USD | 347.8万 USD | 181.7万 USD |
| 営業利益 | 1.09億 USD | 3749.6万 USD | −2872.7万 USD | −3143.7万 USD | −3942.8万 USD |
| 純利益 | 1.9億 USD | 3546.4万 USD | −2502.8万 USD | −3623.1万 USD | −4421.5万 USD |
会社概要が更新されました 2026年10月11日.
発表済み実績と利用可能なコンセンサス予想。
発表済み実績と利用可能なコンセンサス予想。
第三者のアナリスト予想は変更される場合があり、GoAIの推奨ではありません。
平均目標
$99.75
上昇余地（28.10%）この株式へのエクスポージャーを報告している上場投資信託です。
iShares Core S&P Small-Cap ETFIJR1.64億0.16%1031.91億 USD0.06%$137.55+0.17%
Vanguard Morningstar Total Stock Market ETFVTI8839.14万0.00%2.3兆 USD0.03%$381.94+0.63%
iShares Russell 2000 ETFIWM7108.97万0.09%787.4億 USD0.19%$278.94+0.49%
Vanguard Morningstar Small-Cap ETFVB6406.5万0.03%1853億 USD0.03%$289.48+0.64%
Vanguard Morningstar Small-Cap Growth ETFVBK3670.16万0.08%447億 USD0.05%$344.74+1.22%
Vanguard Extended Market ETFVXF3410.28万0.04%954億 USD0.05%$235+0.80%
State Street SPDR Portfolio S&P 600 Small Cap ETFSPSM2525.39万0.16%158.4億 USD0.03%$53.45+0.17%
iShares Russell 2000 Growth ETFIWO2504.85万0.18%139.17億 USD0.24%$356.78+0.94%iShares Core S&P Small-Cap ETFIJRVanguard Morningstar Total Stock Market ETFVTIiShares Russell 2000 ETFIWMVanguard Morningstar Small-Cap ETFVBVanguard Morningstar Small-Cap Growth ETFVBKVanguard Extended Market ETFVXFState Street SPDR Portfolio S&P 600 Small Cap ETFSPSMiShares Russell 2000 Growth ETFIWOAIが生成した遅延市場データを、情報提供および教育目的で掲載しています。投資助言ではありません。
